Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer

BACKGROUND: The prognosis of non-small-cell lung cancer (NSCLC) with brain metastases is very poor. Currently, therapeutic methods for this patient population include whole-brain radiation therapy (WBRT), surgery, radiosurgery and systemic treatment. Epidermal growth factor receptor tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kejun, Jiang, Guanming, Zhang, Ailing, Li, Zhuanghua, Jia, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993327/
https://www.ncbi.nlm.nih.gov/pubmed/32000711
http://dx.doi.org/10.1186/s12885-020-6543-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993327/
https://www.ncbi.nlm.nih.gov/pubmed/32000711
http://dx.doi.org/10.1186/s12885-020-6543-y

Ejemplares similares